奥兰诺芬
硫氧还蛋白还原酶
机制(生物学)
药品
药理学
化学
硫氧还蛋白
计算生物学
生物化学
医学
生物
酶
内科学
物理
类风湿性关节炎
量子力学
作者
Xiaofeng Wang,Yingnan Liu,Li Su,Jiaxin Chen,Yanqiao Zeng,Guofang Zhang,Yang Li
摘要
Auranofin (AF), an established gold (I) complex historically utilized in rheumatoid arthritis treatment, is being repurposed as a novel anticancer agent. This investigation assesses the chemosensitizing capacity of AF to potentiate the cytotoxic effects of doxorubicin (DOX) in melanoma cell models, including drug-sensitive (B16F10) and multidrug-resistant (B16F10/ADR) variants. Our findings reveal that cotreatment with AF and DOX markedly augments antitumor efficacy, evidenced by diminished cell viability and augmented apoptotic rates. This synergism is attributed to AF's ability to inhibit thioredoxin reductase 1 (TrxR1), thereby compromising the antioxidant defenses of tumor cells and elevating intracellular reactive oxygen species (ROS), which in turn enhances apoptotic pathways. Significantly, AF treatment mitigates the heightened TrxR activity in DOX-resistant cells, thereby intensifying the pro-oxidant effects of DOX and culminating in increased ROS production and cellular demise.Employing molecular docking, molecular dynamics (MD) simulations, and surface plasmon resonance (SPR) assays, we systematically delineated the interaction dynamics between AF and TrxR1. Our data indicate that AF exhibits a high-affinity binding to the selenocysteine residue within the catalytic site of TrxR1, with a binding footprint that partially overlaps with that of the endogenous substrate, thioredoxin (Trx), yet with greater avidity. This unique binding configuration is instrumental in AF's ability to impede the reduction of Trx by TrxR1, thus instigating an apoptotic response in cancer cells.In summation, this study underscores the chemosensitizing potential of Auranofin in surmounting multidrug resistance in cancer therapy through redox modulation and elucidates its molecular mechanism of action on TrxR1. These findings pave the way for the clinical application of Auranofin as a chemosensitizer, offering a novel approach to augment the efficacy of existing chemotherapy regimens.
科研通智能强力驱动
Strongly Powered by AbleSci AI